EconomicCanada·16 Oct 2026
Avicanna Transitions US Listing to OTCQB
AI-summarized · Neutrality-checked
On October 16, 2026, the Toronto-based biopharmaceutical company Avicanna Inc. transitioned its United States stock listing to the OTCQB market. Avicanna maintains a focus on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, operating through four business pillars including the RHO Phyto medical cannabis…
Loading full story…
Sources and context
Financial Post
NewspaperCompany ownedCanadaStandards not yet verified
Source-level context, not a score for this article. Methodology and evidence · Report outdated information
Know where. Know why.